Symbols / RDY Stock $13.30 -0.45% Dr. Reddy's Laboratories Limited

Healthcare • Drug Manufacturers - Specialty & Generic • India • NYQ
RDY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Erez Israeli M.B.A.
Exch · Country NYQ · India
Market Cap 11.07B
Enterprise Value 59.24B
Income 42.85B
Sales 335.93B
FCF (ttm) 1.63B
Book/sh 0.79
Cash/sh 17.61
Employees 27,527
Insider 10d —
IPO Apr 11, 2001
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 15.60%
P/E 24.63
Forward P/E 20.11
PEG 1.61
P/S 0.03
P/B 16.90
P/C —
EV/EBITDA 0.87
EV/Sales 0.18
Quick Ratio 1.13
Current Ratio 1.80
Debt/Eq 20.33
LT Debt/Eq —
EPS (ttm) 0.54
EPS next Y 0.66
EPS Growth -86.20%
Revenue Growth -11.60%
EPS Gr Q/Q -86.20%
Rev Gr Q/Q —
Earnings (next) 2026-07-23
Earnings (prior) 2025-05-09
ROA 5.74%
ROE 11.83%
ROIC —
Gross Margin 52.77%
Oper. Margin 1.54%
Profit Margin 12.76%
Shs Outstand 832.70M
Shs Float 3.59B
Insider Own 0.00%
Instit Own 15.29%
Short Float 3.26%
Short Ratio 8.29
Short Interest 22.39M
52W High 15.89
vs 52W High -16.30%
52W Low 12.19
vs 52W Low 9.11%
Beta 0.26
Impl. Vol. 28.68%
Rel Volume 0.42
Avg Volume 2.41M
Volume 1.01M
Target (mean) $14.24
Tgt Median $14.03
Tgt Low $11.47
Tgt High $16.81
# Analysts 5
Recom Hold
Prev Close $13.36
Price $13.30
Change -0.45%
About

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$14.24
Mean price target
2. Current target
$13.30
Latest analyst target
3. DCF / Fair value
$35.18
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$13.30
Low
$11.47
High
$16.81
Mean
$14.24

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-06-05 up HSBC Hold → Buy $17
2024-11-06 main Barclays Overweight → Overweight $17
2024-07-30 main Barclays Overweight → Overweight $87
2024-05-08 main Barclays Overweight → Overweight $81
2024-01-29 main Barclays Overweight → Overweight $80
2023-06-01 main Barclays Overweight → Overweight $70
2022-10-31 main Barclays — → Overweight $67
2022-10-25 main Barclays — → Overweight $66
2022-09-12 main Barclays — → Overweight $69
2022-07-25 main Barclays — → Overweight $68
2022-05-24 main Barclays — → Overweight $70
2021-11-01 main Barclays — → Overweight $80
2021-02-02 up Barclays Equal-Weight → Overweight $70
2020-01-28 down CLSA Buy → Outperform —
2020-01-09 up Citigroup Sell → Buy —
2019-11-04 down B of A Securities Buy → Neutral —
2019-09-04 up Credit Suisse Underperform → Outperform —
2019-06-11 init Barclays — → Equal-Weight $39
2019-05-20 down Morgan Stanley Overweight → Equal-Weight —
2017-11-01 main Jefferies — → Underperform $31
News
RSS: Latest RDY news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total Revenue
335,933.00
+3.19%
325,535.00
+16.61%
279,164.00
+13.54%
245,879.00
Operating Revenue
335,933.00
+3.19%
325,535.00
+16.61%
279,164.00
+13.54%
245,879.00
Cost Of Revenue
158,669.00
+17.44%
135,107.00
+16.92%
115,557.00
+8.47%
106,536.00
Reconciled Cost Of Revenue
158,669.00
+17.44%
135,107.00
+16.92%
115,557.00
+8.47%
106,536.00
Gross Profit
177,264.00
-6.91%
190,428.00
+16.39%
163,607.00
+17.41%
139,343.00
Operating Expense
127,141.00
+7.37%
118,414.00
+20.46%
98,299.00
+22.43%
80,289.00
Research And Development
24,058.00
-12.13%
27,380.00
+19.70%
22,873.00
+18.02%
19,381.00
Selling General And Administration
106,763.00
+13.73%
93,870.00
+21.59%
77,201.00
+13.49%
68,026.00
General And Administrative Expense
59,909.00
+7.36%
55,800.00
—
—
Salaries And Wages
59,909.00
+7.36%
55,800.00
—
—
Other Operating Expenses
-3,680.00
-29.76%
-2,836.00
-59.77%
-1,775.00
+75.06%
-7,118.00
Total Expenses
285,810.00
+12.74%
253,521.00
+18.55%
213,856.00
+14.47%
186,825.00
Operating Income
50,123.00
-30.40%
72,014.00
+10.27%
65,308.00
+10.59%
59,054.00
Total Operating Income As Reported
50,551.00
-29.64%
71,843.00
+6.07%
67,729.00
+18.52%
57,144.00
EBITDA
79,160.00
-18.11%
96,671.00
+9.33%
88,422.00
+18.80%
74,431.00
Normalized EBITDA
74,588.00
-18.90%
91,966.00
+11.37%
82,574.00
+12.74%
73,240.00
Reconciled Depreciation
20,605.00
+20.79%
17,058.00
+14.94%
14,841.00
+17.45%
12,636.00
EBIT
58,555.00
-26.45%
79,613.00
+8.20%
73,581.00
+19.07%
61,795.00
Total Unusual Items
4,572.00
-2.83%
4,705.00
-19.55%
5,848.00
+391.02%
1,191.00
Total Unusual Items Excluding Goodwill
4,572.00
-2.83%
4,705.00
-19.55%
5,848.00
+391.02%
1,191.00
Special Income Charges
428.00
+350.29%
-171.00
-107.06%
2,421.00
+226.75%
-1,910.00
Other Special Charges
-1,400.00
—
-1,524.00
—
Impairment Of Capital Assets
3,519.00
+107.86%
1,693.00
+56333.33%
3.00
-99.57%
699.00
Write Off
—
—
3.00
-99.57%
699.00
Net Income
42,850.00
-24.22%
56,544.00
+1.54%
55,684.00
+23.56%
45,067.00
Pretax Income
54,817.00
-28.61%
76,784.00
+6.84%
71,870.00
+19.06%
60,367.00
Net Non Operating Interest Income Expense
-12.00
+92.11%
-152.00
-126.81%
567.00
+328.63%
-248.00
Interest Expense Non Operating
3,738.00
+32.13%
2,829.00
+65.34%
1,711.00
+19.82%
1,428.00
Net Interest Income
-12.00
+92.11%
-152.00
-126.81%
567.00
+328.63%
-248.00
Interest Expense
3,738.00
+32.13%
2,829.00
+65.34%
1,711.00
+19.82%
1,428.00
Interest Income Non Operating
3,726.00
+39.19%
2,677.00
+17.52%
2,278.00
+93.05%
1,180.00
Interest Income
3,726.00
+39.19%
2,677.00
+17.52%
2,278.00
+93.05%
1,180.00
Other Income Expense
4,706.00
-4.39%
4,922.00
-17.90%
5,995.00
+284.05%
1,561.00
Other Non Operating Income Expenses
13,584.00
+23.79%
10,973.00
—
—
Gain On Sale Of Security
4,144.00
-15.01%
4,876.00
+42.28%
3,427.00
+10.51%
3,101.00
Tax Provision
12,351.00
-36.79%
19,539.00
+20.72%
16,186.00
+5.79%
15,300.00
Tax Rate For Calcs
0.00
-8.00%
0.00
+8.70%
0.00
-8.00%
0.00
Tax Effect Of Unusual Items
1,051.56
-10.60%
1,176.25
-12.55%
1,345.04
+351.73%
297.75
Net Income Including Noncontrolling Interests
42,466.00
-25.82%
57,245.00
+2.80%
55,684.00
+23.56%
45,067.00
Net Income From Continuing Operation Net Minority Interest
42,850.00
-24.22%
56,544.00
+1.54%
55,684.00
+23.56%
45,067.00
Net Income From Continuing And Discontinued Operation
42,850.00
-24.22%
56,544.00
+1.54%
55,684.00
+23.56%
45,067.00
Net Income Continuous Operations
42,466.00
-25.82%
57,245.00
+2.80%
55,684.00
+23.56%
45,067.00
Minority Interests
384.00
+154.78%
-701.00
0.00
0.00
Normalized Income
39,329.56
-25.81%
53,015.25
+3.58%
51,181.04
+15.86%
44,173.75
Net Income Common Stockholders
42,850.00
-24.22%
56,544.00
+1.54%
55,684.00
+23.56%
45,067.00
Diluted EPS
51.42
-24.14%
67.78
+1.29%
66.92
+23.51%
54.18
Basic EPS
51.48
-24.16%
67.88
+1.25%
67.04
+23.48%
54.29
Basic Average Shares
832.44
-0.06%
832.95
+0.12%
831.98
+0.22%
830.17
Diluted Average Shares
833.33
-0.10%
834.18
+0.08%
833.54
+0.20%
831.91
Diluted NI Availto Com Stockholders
42,850.00
-24.22%
56,544.00
+1.54%
55,684.00
+23.56%
45,067.00
Depreciation Amortization Depletion Income Statement
20,588.00
+20.84%
17,037.00
—
—
Depreciation And Amortization In Income Statement
20,588.00
+20.84%
17,037.00
—
—
Earnings From Equity Interest
134.00
-38.25%
217.00
+47.62%
147.00
-60.27%
370.00
Gain On Sale Of PPE
2,547.00
+67.35%
1,522.00
+69.11%
900.00
+174.32%
-1,211.00
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total Assets
579,346.00
+17.52%
492,989.00
+27.22%
387,518.00
+20.40%
321,854.00
Current Assets
301,975.00
+20.74%
250,112.00
+0.83%
248,049.00
+21.44%
204,253.00
Cash Cash Equivalents And Short Term Investments
87,814.00
+51.64%
57,908.00
-28.92%
81,470.00
+31.83%
61,797.00
Cash And Cash Equivalents
15,368.00
+4.87%
14,654.00
+106.19%
7,107.00
+22.98%
5,779.00
Cash Equivalents
1,118.00
-55.48%
2,511.00
-2.86%
2,585.00
-5.76%
2,743.00
Cash Financial
14,250.00
+17.35%
12,143.00
+168.53%
4,522.00
+48.95%
3,036.00
Other Short Term Investments
72,446.00
+67.49%
43,254.00
-41.83%
74,363.00
+32.75%
56,018.00
Receivables
123,172.00
+12.19%
109,792.00
+15.16%
95,338.00
+14.58%
83,203.00
Accounts Receivable
101,219.00
+11.94%
90,420.00
+12.61%
80,298.00
+10.78%
72,485.00
Gross Accounts Receivable
103,066.00
+12.15%
91,898.00
+12.41%
81,749.00
+10.86%
73,743.00
Allowance For Doubtful Accounts Receivable
-1,847.00
-24.97%
-1,478.00
-1.86%
-1,451.00
-15.34%
-1,258.00
Other Receivables
21,953.00
+13.32%
19,372.00
+28.80%
15,040.00
+40.32%
10,718.00
Taxes Receivable
—
—
—
2,687.00
Inventory
76,531.00
+7.66%
71,085.00
+11.85%
63,552.00
+30.58%
48,670.00
Raw Materials
27,377.00
+4.63%
26,165.00
+8.65%
24,081.00
+50.50%
16,001.00
Work In Process
16,054.00
-2.85%
16,525.00
+16.19%
14,222.00
+21.58%
11,698.00
Finished Goods
33,100.00
+16.57%
28,395.00
+12.46%
25,249.00
+20.40%
20,971.00
Prepaid Assets
8,280.00
+3.45%
8,004.00
+68.54%
4,749.00
+13.72%
4,176.00
Assets Held For Sale Current
—
—
—
—
Hedging Assets Current
155.00
-72.17%
557.00
+229.59%
169.00
-86.28%
1,232.00
Other Current Assets
6,023.00
+117.75%
2,766.00
-0.18%
2,771.00
-46.45%
5,175.00
Total Non Current Assets
277,371.00
+14.20%
242,877.00
+74.14%
139,469.00
+18.60%
117,601.00
Net PPE
115,930.00
+18.59%
97,761.00
+27.15%
76,886.00
+15.68%
66,462.00
Gross PPE
219,796.00
+15.45%
190,380.00
+11.90%
170,140.00
+11.74%
152,269.00
Accumulated Depreciation
-103,866.00
-12.14%
-92,619.00
+0.68%
-93,254.00
-8.68%
-85,807.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
4,346.00
+2.43%
4,243.00
-1.53%
4,309.00
-0.21%
4,318.00
Buildings And Improvements
44,840.00
+29.40%
34,653.00
+4.91%
33,032.00
+11.13%
29,724.00
Machinery Furniture Equipment
155,200.00
+22.55%
126,646.00
+7.02%
118,338.00
+9.30%
108,268.00
Construction In Progress
15,409.00
-37.96%
24,838.00
+71.77%
14,460.00
+45.24%
9,956.00
Other Properties
—
—
3.00
+0.00%
3.00
Goodwill And Other Intangible Assets
117,952.00
+8.60%
108,613.00
+163.60%
41,204.00
+17.41%
35,094.00
Goodwill
12,893.00
+9.17%
11,810.00
+177.69%
4,253.00
+0.19%
4,245.00
Other Intangible Assets
105,059.00
+8.53%
96,803.00
+161.98%
36,951.00
+19.78%
30,849.00
Investments And Advances
16,368.00
+7.67%
15,202.00
+189.29%
5,255.00
-2.00%
5,362.00
Long Term Equity Investment
5,673.00
+17.92%
4,811.00
+14.66%
4,196.00
-10.76%
4,702.00
Other Investments
10,695.00
—
—
—
Non Current Accounts Receivable
3,459.00
+89.95%
1,821.00
-51.02%
3,718.00
+38.37%
2,687.00
Non Current Deferred Assets
22,436.00
+21.22%
18,508.00
+71.78%
10,774.00
+49.72%
7,196.00
Non Current Deferred Taxes Assets
22,436.00
+21.22%
18,508.00
+71.78%
10,774.00
+49.72%
7,196.00
Non Current Prepaid Assets
904.00
+20.53%
750.00
+0.40%
747.00
+11.83%
668.00
Other Non Current Assets
322.00
+45.05%
222.00
-74.92%
885.00
+570.45%
132.00
Total Liabilities Net Minority Interest
198,889.00
+27.64%
155,823.00
+45.67%
106,968.00
+17.72%
90,863.00
Current Liabilities
167,566.00
+28.51%
130,392.00
+35.77%
96,039.00
+11.87%
85,845.00
Payables And Accrued Expenses
77,160.00
+1.55%
75,984.00
+9.87%
69,157.00
+10.69%
62,477.00
Payables
49,240.00
-3.16%
50,849.00
+14.59%
44,374.00
+9.21%
40,633.00
Accounts Payable
22,362.00
+11.51%
20,053.00
-6.93%
21,547.00
+20.66%
17,857.00
Other Payable
22,568.00
-18.73%
27,768.00
+35.55%
20,485.00
-0.71%
20,632.00
Current Accrued Expenses
27,920.00
+11.08%
25,135.00
+1.42%
24,783.00
+13.45%
21,844.00
Total Tax Payable
4,310.00
+42.34%
3,028.00
+29.29%
2,342.00
+9.24%
2,144.00
Current Debt And Capital Lease Obligation
65,138.00
+67.44%
38,902.00
+177.28%
14,030.00
+15.06%
12,194.00
Current Debt
62,934.00
+65.42%
38,045.00
+199.03%
12,723.00
+13.70%
11,190.00
Other Current Borrowings
3,799.00
—
10,223.00
+169.03%
3,800.00
Current Capital Lease Obligation
2,204.00
+157.18%
857.00
-34.43%
1,307.00
+30.18%
1,004.00
Current Deferred Liabilities
1,581.00
-20.27%
1,983.00
+38.19%
1,435.00
-27.56%
1,981.00
Current Deferred Revenue
1,581.00
-20.27%
1,983.00
+38.19%
1,435.00
-27.56%
1,981.00
Other Current Liabilities
16,137.00
+119.40%
7,355.00
+21.89%
6,034.00
+61.38%
3,739.00
Total Non Current Liabilities Net Minority Interest
31,323.00
+23.17%
25,431.00
+132.69%
10,929.00
+117.80%
5,018.00
Long Term Debt And Capital Lease Obligation
12,203.00
+55.18%
7,864.00
+31.29%
5,990.00
+368.70%
1,278.00
Long Term Debt
12,203.00
+221.13%
3,800.00
+0.00%
3,800.00
—
Long Term Capital Lease Obligation
12,203.00
+200.27%
4,064.00
+85.57%
2,190.00
+71.36%
1,278.00
Long Term Provisions
109.00
-30.13%
156.00
+155.74%
61.00
+3.39%
59.00
Non Current Deferred Liabilities
18,004.00
+17.90%
15,270.00
+626.45%
2,102.00
-11.98%
2,388.00
Non Current Deferred Revenue
2,436.00
+109.64%
1,162.00
-2.60%
1,193.00
-23.28%
1,555.00
Non Current Deferred Taxes Liabilities
15,568.00
+10.35%
14,108.00
+1452.04%
909.00
+9.12%
833.00
Other Non Current Liabilities
1,007.00
-52.97%
2,141.00
-22.87%
2,776.00
+114.69%
1,293.00
Stockholders Equity
377,063.00
+13.10%
333,388.00
+18.83%
280,550.00
+21.45%
230,991.00
Common Stock Equity
377,063.00
+13.10%
333,388.00
+18.83%
280,550.00
+21.45%
230,991.00
Capital Stock
835.00
+0.12%
834.00
+0.00%
834.00
+0.12%
833.00
Common Stock
835.00
+0.12%
834.00
+0.00%
834.00
+0.12%
833.00
Share Issued
834.66
+0.02%
834.46
+0.04%
834.09
+0.17%
832.64
Ordinary Shares Number
832.45
+0.05%
832.00
-0.08%
832.64
+0.22%
830.78
Treasury Shares Number
2.21
-10.05%
2.45
+69.24%
1.45
-21.92%
1.86
Additional Paid In Capital
11,537.00
+2.04%
11,306.00
+3.36%
10,938.00
+6.81%
10,241.00
Retained Earnings
351,984.00
+11.46%
315,793.00
+19.05%
265,257.00
+23.04%
215,593.00
Gains Losses Not Affecting Retained Earnings
3,979.00
+0.00%
3,979.00
+509.34%
653.00
-26.30%
886.00
Treasury Stock
1,815.00
-19.83%
2,264.00
+128.46%
991.00
-21.91%
1,269.00
Minority Interest
3,394.00
-10.16%
3,778.00
0.00
—
Other Equity Adjustments
3,979.00
+0.00%
3,979.00
+509.34%
653.00
-26.30%
886.00
Total Equity Gross Minority Interest
380,457.00
+12.84%
337,166.00
+20.18%
280,550.00
+21.45%
230,991.00
Total Capitalization
377,063.00
+11.83%
337,188.00
+18.58%
284,350.00
+23.10%
230,991.00
Working Capital
134,409.00
+12.27%
119,720.00
-21.24%
152,010.00
+28.38%
118,408.00
Invested Capital
439,997.00
+17.26%
375,233.00
+26.31%
297,073.00
+22.67%
242,181.00
Total Debt
77,341.00
+65.38%
46,766.00
+133.60%
20,020.00
+48.60%
13,472.00
Net Debt
47,566.00
+74.93%
27,191.00
+188.77%
9,416.00
+74.02%
5,411.00
Capital Lease Obligations
14,407.00
+192.77%
4,921.00
+40.72%
3,497.00
+53.24%
2,282.00
Net Tangible Assets
259,111.00
+15.28%
224,775.00
-6.09%
239,346.00
+22.18%
195,897.00
Tangible Book Value
259,111.00
+15.28%
224,775.00
-6.09%
239,346.00
+22.18%
195,897.00
Available For Sale Securities
7,958.00
-12.07%
9,050.00
+3534.54%
249.00
-11.70%
282.00
Current Provisions
7,550.00
+22.41%
6,168.00
+14.58%
5,383.00
-1.30%
5,454.00
Financial Assets Designatedas Fair Value Through Profitor Loss Total
2,737.00
+104.10%
1,341.00
+65.56%
810.00
+114.29%
378.00
Investmentin Financial Assets
10,695.00
+2.93%
10,391.00
+881.21%
1,059.00
+60.45%
660.00
Line Of Credit
59,135.00
+55.43%
38,045.00
+199.03%
12,723.00
+72.17%
7,390.00
Other Equity Interest
10,543.00
+181.90%
3,740.00
-3.08%
3,859.00
-18.02%
4,707.00
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Operating Cash Flow
56,755.00
+22.24%
46,428.00
+2.19%
45,433.00
-22.83%
58,875.00
Cash Flow From Continuing Operating Activities
56,755.00
+22.24%
46,428.00
+2.19%
45,433.00
-22.83%
58,875.00
Net Income From Continuing Operations
42,466.00
-25.82%
57,245.00
+2.80%
55,684.00
+23.56%
45,067.00
Depreciation Amortization Depletion
20,605.00
+20.79%
17,058.00
+14.94%
14,841.00
+17.45%
12,636.00
Depreciation
12,620.00
+20.13%
10,505.00
+9.70%
9,576.00
—
Amortization Cash Flow
7,985.00
+21.85%
6,553.00
+24.46%
5,265.00
—
Depreciation And Amortization
20,605.00
+20.79%
17,058.00
+14.94%
14,841.00
+17.45%
12,636.00
Amortization Of Intangibles
7,985.00
+21.85%
6,553.00
+24.46%
5,265.00
—
Other Non Cash Items
12.00
-92.11%
152.00
+126.81%
-567.00
-328.63%
248.00
Stock Based Compensation
326.00
-23.11%
424.00
+4.18%
407.00
+2.52%
397.00
Provisionand Write Offof Assets
690.00
+328.57%
161.00
-41.45%
275.00
+34.15%
205.00
Asset Impairment Charge
11,036.00
+59.64%
6,913.00
+93.86%
3,566.00
-35.96%
5,568.00
Deferred Tax
12,351.00
-36.79%
19,539.00
+20.72%
16,186.00
+5.79%
15,300.00
Deferred Income Tax
12,351.00
-36.79%
19,539.00
+20.72%
16,186.00
+5.79%
15,300.00
Operating Gains Losses
-3,210.00
-110.08%
-1,528.00
+3.35%
-1,581.00
-43.60%
-1,101.00
Unrealized Gain Loss On Investment Securities
-2,359.00
+33.62%
-3,554.00
-12.86%
-3,149.00
-259.47%
-876.00
Net Foreign Currency Exchange Gain Loss
-529.00
-350.71%
211.00
+139.51%
-534.00
+43.13%
-939.00
Change In Working Capital
-11,636.00
+61.20%
-29,989.00
-48.59%
-20,182.00
-156.93%
-7,855.00
Change In Receivables
-6,722.00
+34.63%
-10,283.00
-27.68%
-8,054.00
-40.02%
-5,752.00
Changes In Account Receivables
-6,722.00
+34.63%
-10,283.00
—
—
Change In Inventory
-8,601.00
+32.56%
-12,753.00
+30.86%
-18,445.00
-594.99%
-2,654.00
Change In Payables And Accrued Expense
2,790.00
+720.59%
340.00
-90.17%
3,460.00
+14943.48%
23.00
Change In Payable
2,790.00
+720.59%
340.00
-90.17%
3,460.00
+14943.48%
23.00
Change In Account Payable
2,790.00
+720.59%
340.00
—
—
Change In Other Working Capital
897.00
+112.30%
-7,293.00
-355.27%
2,857.00
+441.10%
528.00
Investing Cash Flow
-65,513.00
-12.80%
-58,077.00
-44.17%
-40,283.00
+2.63%
-41,373.00
Cash Flow From Continuing Investing Activities
-65,513.00
-12.80%
-58,077.00
-44.17%
-40,283.00
+2.63%
-41,373.00
Net PPE Purchase And Sale
-23,017.00
+14.73%
-26,992.00
-75.97%
-15,339.00
-36.46%
-11,241.00
Purchase Of PPE
-23,326.00
+15.19%
-27,504.00
-67.68%
-16,403.00
-44.86%
-11,323.00
Sale Of PPE
309.00
-39.65%
512.00
-51.88%
1,064.00
+1197.56%
82.00
Capital Expenditure
-38,425.00
-11.71%
-34,398.00
-25.38%
-27,435.00
-45.42%
-18,866.00
Capital Expenditure Reported
—
—
—
-18,866.00
Net Investment Purchase And Sale
-27,116.00
-207.95%
25,118.00
+259.95%
-15,704.00
+32.79%
-23,366.00
Purchase Of Investment
-46,718.00
-63.97%
-28,492.00
+31.59%
-41,648.00
+69.41%
-136,171.00
Sale Of Investment
19,602.00
-63.44%
53,610.00
+106.64%
25,944.00
-77.00%
112,805.00
Net Business Purchase And Sale
-3,203.00
+94.00%
-53,413.00
-445008.33%
-12.00
0.00
Purchase Of Business
-3,203.00
+94.00%
-53,413.00
-445008.33%
-12.00
0.00
Net Intangibles Purchase And Sale
-13,698.00
-122.30%
-6,162.00
+44.04%
-11,011.00
-45.98%
-7,543.00
Purchase Of Intangibles
-15,099.00
-119.02%
-6,894.00
+37.51%
-11,032.00
-46.25%
-7,543.00
Financing Cash Flow
8,290.00
-56.16%
18,911.00
+602.55%
-3,763.00
+85.99%
-26,861.00
Cash Flow From Continuing Financing Activities
8,290.00
-56.16%
18,911.00
+602.55%
-3,763.00
+85.99%
-26,861.00
Net Issuance Payments Of Debt
18,993.00
-18.12%
23,196.00
+433.73%
4,346.00
+121.31%
-20,397.00
Issuance Of Debt
0.00
0.00
-100.00%
3,800.00
0.00
Repayment Of Debt
-1,264.00
+2.32%
-1,294.00
+73.84%
-4,947.00
-387.39%
-1,015.00
Long Term Debt Issuance
0.00
0.00
-100.00%
3,800.00
0.00
Long Term Debt Payments
-1,264.00
+2.32%
-1,294.00
+73.84%
-4,947.00
-387.39%
-1,015.00
Net Long Term Debt Issuance
-1,264.00
+2.32%
-1,294.00
-12.82%
-1,147.00
-13.00%
-1,015.00
Short Term Debt Issuance
20,257.00
-17.28%
24,490.00
—
—
Short Term Debt Payments
—
—
—
-19,382.00
Net Short Term Debt Issuance
20,257.00
-17.28%
24,490.00
+345.84%
5,493.00
+128.34%
-19,382.00
Net Common Stock Issuance
397.00
+133.19%
-1,196.00
-248.57%
805.00
+118.75%
368.00
Common Stock Payments
0.00
+100.00%
-1,389.00
0.00
0.00
Cash Dividends Paid
-6,659.00
+0.05%
-6,662.00
-0.21%
-6,648.00
-33.52%
-4,979.00
Repurchase Of Capital Stock
0.00
+100.00%
-1,389.00
0.00
0.00
Net Other Financing Charges
—
7,056.00
—
—
Changes In Cash
-468.00
-106.44%
7,262.00
+423.58%
1,387.00
+114.82%
-9,359.00
Effect Of Exchange Rate Changes
1,243.00
+454.91%
224.00
+479.66%
-59.00
-120.63%
286.00
Beginning Cash Position
14,593.00
+105.33%
7,107.00
+22.98%
5,779.00
-61.09%
14,852.00
End Cash Position
15,368.00
+5.31%
14,593.00
+105.33%
7,107.00
+22.98%
5,779.00
Free Cash Flow
18,330.00
+52.37%
12,030.00
-33.16%
17,998.00
-55.02%
40,009.00
Common Stock Issuance
397.00
+105.70%
193.00
-76.02%
805.00
+118.75%
368.00
Dividends Received CFI
0.00
0.00
-100.00%
445.00
0.00
Earnings Losses From Equity Investments
-134.00
+38.25%
-217.00
-47.62%
-147.00
+60.27%
-370.00
Interest Paid CFF
-4,441.00
-27.51%
-3,483.00
-53.71%
-2,266.00
-22.29%
-1,853.00
Interest Received CFI
1,521.00
-54.89%
3,372.00
+152.02%
1,338.00
+72.20%
777.00
Issuance Of Capital Stock
397.00
+105.70%
193.00
-76.02%
805.00
+118.75%
368.00
Sale Of Intangibles
1,401.00
+91.39%
732.00
+3385.71%
21.00
0.00
Taxes Refund Paid
-13,526.00
+32.35%
-19,993.00
+0.27%
-20,047.00
-87.11%
-10,714.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category